1-12 of 12
Federica Guffanti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 945: In vivo anti-tumor activity of onvansertib, a PLK1 inhibitor, combined with gemcitabine or carboplatin in platinum- resistant ovarian carcinoma patient-derived xenograft models

Michela Chiappa, Federica Guffanti, Ilaria Mengoli, Maya Ridinger, Giovanna Damia
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 945.
https://doi.org/10.1158/1538-7445.AM2024-945
Published: 22 March 2024
View article titled, Abstract 945: <em>In vivo</em> anti-tumor activity of onvansertib, a PLK1 inhibitor, combined with gemcitabine or carboplatin in platinum- resistant ovarian carcinoma patient-derived xenograft models
Journal Articles

Abstract 3237: Combining PARP inhibition with the polo-like kinase 1 (PLK1) inhibitor onvansertib overcomes PARP inhibitor resistance

Michela Chiappa, Federica Guffanti, Alessandra Decio, Alessandro Aliverti, Francesca Ricci, Eugenio Scanziani, Federica Camin, Ilaria Craparotta, Maria Chiara Barbera, Marco Bolis, Maya Ridinger, Giovanna Damia
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3237.
https://doi.org/10.1158/1538-7445.AM2022-3237
Published: 15 June 2022
View article titled, Abstract 3237: Combining PARP inhibition with the polo-like kinase 1 (PLK1) inhibitor onvansertib overcomes PARP inhibitor resistance
Journal Articles

Abstract 3244: Exploring the mechanisms of olaparib resistance in resistant-BRCA1 deficient murine ovarian cells

Michela Chiappa, Martina Anselmi, Luca Russo, Monica Lupi, Nicolò Panini, Federica Guffanti, Giovanna Damia
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3244.
https://doi.org/10.1158/1538-7445.AM2022-3244
Published: 15 June 2022
View article titled, Abstract 3244: Exploring the mechanisms of olaparib resistance in resistant-BRCA1 deficient murine ovarian cells
Journal Articles

Abstract P5-14-01: Eribulin tolerability and correlation between neuropathy and a set of polymorphisms in metastatic breast cancer patients. Results from the PAINTER (Polymorphism And Incidence of Toxicity in ERibulin treatment) study

Nicla La Verde, Giovanna Damia, Ornella Garrone, Loretta D'Onofrio, Alessandra Fabi, Mariangela Ciccarese, Daniele Generali, Martina Nunzi, Elena Poletto, Paolo Pedrazzoli, Elisabetta Cretella, Giuseppa Scandurra, Icro Meattini, Alessandro S Bertolini, Luigi Cavanna, Emanuela Romagnoli, Lorenzo Legramandi, Federica Guffanti, Eliana Rulli, Anna Moretti, Barbara Bocci, Gabriella Farina
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-14-01.
https://doi.org/10.1158/1538-7445.SABCS19-P5-14-01
Published: 15 February 2020
View article titled, Abstract P5-14-01: Eribulin tolerability and correlation between neuropathy and a set of polymorphisms in metastatic breast cancer patients. Results from the PAINTER (Polymorphism And Incidence of Toxicity in ERibulin treatment) study
Journal Articles

Abstract 174: Preclinical activity of new liposomal formulation of doxorubicin (TLD-1)

Massimo Broggini, Federica Guffanti, Roberta Affatato, Lavinia Morosi, Patrick Buschor, Christoph Matthieu, Florian Weiss, Andreas Konig, Peter Halbherr, Stefan Halbherr
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 174.
https://doi.org/10.1158/1538-7445.AM2017-174
Published: 01 July 2017
View article titled, Abstract 174: Preclinical activity of new liposomal formulation of doxorubicin (TLD-1)
Journal Articles

Abstract 508: DNA repair status in a patient derived ovarian cancer xenobank

Federica Guffanti, Maddalena Fratelli, Monica Ganzinelli, Francesca Ricci, Roberta Affatato, Maria Rosa Cappelletti, Daniele Generali, Francesca Bizzaro, Massimo Broggini, Raffaella Giavazzi, Giovanna Damia
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 508.
https://doi.org/10.1158/1538-7445.AM2017-508
Published: 01 July 2017
View article titled, Abstract 508: DNA repair status in a patient derived ovarian cancer xenobank
Journal Articles

Abstract 4091: Investigations on the role of epithelial-mesenchymal transition and cancer stem cells in the response to therapy in patient-derived ovarian carcinoma xenografts

Francesca Ricci, Federica Guffanti, Maddalena Fratelli, Broggini Massimo, Giovanna Damia
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4091.
https://doi.org/10.1158/1538-7445.AM2015-4091
Published: 01 August 2015
View article titled, Abstract 4091: Investigations on the role of epithelial-mesenchymal transition and cancer stem cells in the response to therapy in patient-derived ovarian carcinoma xenografts
Journal Articles

Abstract 3500: Combinations of ARQ087 with chemotherapeutic agents are safe and show a striking antitumor activity in different xenograft models

Rosaria Chilà, Federica Guffanti, Terence Hall, Francesca Ricci, Massimo Broggini, Giovanna Damia
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3500.
https://doi.org/10.1158/1538-7445.AM2015-3500
Published: 01 August 2015
View article titled, Abstract 3500: Combinations of ARQ087 with chemotherapeutic agents are safe and show a striking antitumor activity in different xenograft models
Journal Articles

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

Francesca Ricci, Francesca Bizzaro, Marta Cesca, Federica Guffanti, Monica Ganzinelli, Alessandra Decio, Carmen Ghilardi, Patrizia Perego, Robert Fruscio, Alessandro Buda, Rodolfo Milani, Paola Ostano, Giovanna Chiorino, Maria Rosa Bani, Giovanna Damia, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6980–6990.
https://doi.org/10.1158/0008-5472.CAN-14-0274
Published: 30 November 2014
View article titled, Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Open the PDF for Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations in another window
Includes: Supplementary data
Journal Articles

Abstract 2766: Inhibition of Chk1 and Wee1 as a new therapeutic approach in Mantle Cell Lymphoma

Laura Carrassa, Rosaria Chilà, Alessandra Basana, Francesca Ricci, Federica Guffanti, Monica Lupi, Andrea Rinaldi, Luciano Cascione, Francesco Bertoni, Massimo Broggini, Giovanna Damia
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2766.
https://doi.org/10.1158/1538-7445.AM2014-2766
Published: 01 October 2014
View article titled, Abstract 2766: Inhibition of Chk1 and Wee1 as a new therapeutic approach in Mantle Cell Lymphoma
Journal Articles

Abstract 2670: Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models

Ezia Bello, Rosaria Chilà, Federica Guffanti, Monique Zangarini, Laura Ceriani, Massimo Zucchetti, Saba Chaudi, Marie-Jeanne Pierrat, Anne Jacquet-Bescond, Giovanna L.M. Damia
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2670.
https://doi.org/10.1158/1538-7445.AM2014-2670
Published: 01 October 2014
View article titled, Abstract 2670: Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models
Journal Articles

Abstract 3760: Role of epithelial to mesenchymal transition in response to cisplatin in patient-derived ovarian carcinomas

Francesca Ricci, Federica Guffanti, Fratelli Maddalena, Patrizia Perego, Robert Fruscio, Romina Baldo, Sonia Magni, Massimo Broggini, Giovanna Damia
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3760.
https://doi.org/10.1158/1538-7445.AM2014-3760
Published: 01 October 2014
View article titled, Abstract 3760: Role of epithelial to mesenchymal transition in response to cisplatin in patient-derived ovarian carcinomas